c-Met is the other receptor of LECT2, and the c-Met-LECT2 protein–protein interaction (PPI) impedes MET receptor activation to inhibit vascular invasion, metastasis, proliferation, and stemness of several cancers by antagonizing different cancer activation pathways (Figure 2B) (43, 46–48). The gene discussed is LECT2; the disease is cancer.